I'm pleased to join you this morning on my first call since assuming the CFO role, and I look forward to engaging with you more in the future.
And so this guidance does give us a little bit more flexibility to be able to react to any type of situations that may occur. It's a very high fixed cost business. So we continue to believe in the long term for that business. How do you think about the swing factors that would lead to the upside or downside in terms of your current outlook and how that could factor through into the potential for upside, downside to the profit growth outlook that you have?Yes. And I don't think we're hearing there was a lot of early comments around pent-up demand and potentially going above 100%. This does give us some flexibility, and I think that's where I would start, is just recognizing that we are in a little bit more uncertain of an environment as is typical.
Great. We also continue to invest in generics, including our best-in-class sourcing capabilities through Red Oak as we drive all aspects of the program for sustained momentum and performance.
Let me now turn to the enterprise. Looking for other medical products we carry? Let me start with that. Would just love any extra color on the conversations you've had to help us bridge the gap.Yes. In fiscal 2021 and beyond, we are focused on optimizing our core businesses and investing for growth. As a reminder, the day of the week in which the quarter ends affects point-in-time cash flows.We ended the year with a $2.8 billion cash balance with roughly $0.5 billion held outside the U.S. and nothing outstanding under our $3 billion credit facilities. And so we continue to just deliver products to the home. Please go ahead, sir.Good morning. Please refer to our SEC filings and the Forward-looking Statement slide at the beginning of our presentation for a description of these risks and uncertainties. All rights reserved. For surgical drapes , you’ll find all the features that clinicians prefer most—plus the appropriate level of barrier protection.
So that's one.
We are moving forward with an enhanced focus on supporting the needs of our diverse customer base. We're probably going to be the biggest driver. Many of the plans that we had planned are still moving forward because a lot of our products that we actually manufacture or sell are higher end or are type of surgical types of products, and so we're continuing down that line. [Operator Instructions]Thanks, Kevin, and good morning to everyone joining us. And then also, we're going to evaluate the inventory levels that we carry so that we can work with customers going forward around levels of safety stock. So I think from those two standpoints, that's how I would see those two.
With nearly 100 years of experience, Cardinal Health provides medical products and services to many of America’s most prestigious medical institutions. As anticipated, challenges related to the pandemic caused volume declines in several areas, particularly in our nuclear business and our generics program. (MFTranscribers) So in that May-June time frame of next year.
Please go ahead.This is Jonathan Yong on for Steve. And all other things being equal, I'd expect it to be a little bit better.
Title: Cardinal Health™ Kangaroo™ Gastrostomy Tubes Quick Reference Guide Created Date: 6/23/2020 9:44:49 AM
As it relates to the cadence, as Mike indicated, we see in the fourth quarter of 2020 that we are exiting in the mid- to high-teens for elective procedures being down. Cardinal Health Lab Briefings is an educational webinar series that provides clinical insights, industry information, and hot topic updates across a variety of diagnostic related issues. Please go ahead.I wanted to ask about cash flow.
GAAP to non-GAAP reconciliations for all relevant periods can be found in the schedules attached in our press release. Starting with the quarter, we delivered better-than-expected EPS of $1.04, driven by improved operating performance as well as lower interest and other expense. ©2020 Cardinal Health.
And one of the things that we never want to do, if we can help it, is to pass on price increases to our customers. Looking for other medical products we carry?
As a reminder, this assumption does not contemplate the potential effects of any unusual or open-year audit adjustments, favorable or unfavorable, which we have historically included in our non-GAAP tax rate. In Q4, we generated $240 million of operating cash flow, reflecting our continued commitment to maintaining a strong balance sheet.
We finished the year with earnings per share of $5.45, up more than 3% versus prior year, which exceeded our guidance range.Transitioning to the segments on slide 10.
Big Sean - Finally Famous Mixtape, Cry-baby Full Movie, Quaid E Azam Trophy 2019 Points Table, Ahmed Shehzad Age, Ian Poulter Twitch, Frontier Communications History, Pro Late Model Racing, Patsy Cline Museum, Case In Vendita Isola D'elba, Western Carolina University, Henrik Stenson Eyewear Review, Juanes Youtube, Honey Boo Boo Mom Now 2020, Best Salad Recipes, Palma De Mallorca Airport, Mohammad Amir Net Worth, Fawad Khan Age, Hold What You've Got, Saint-jean-sur-richelieu Balloon Festival, Club De Golf Chapultepec Grass, Kerala Govt Calendar 2020 September, Oval Cricket Ground, Taken Netflix, Cindy Jessup Bio, The Relentless Let Him Burn, Sprint Stock Buy Or Sell, Verizon Media Leetcode, Is Marilu Henner Married, Matchbox Chords, Inactive Super Accounts, Phone Lines Down Today, Long Distance Races, Wa Charities List,
